Review



massarray single nucleotide polymorphism snp technology  (Sequenom)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Sequenom massarray single nucleotide polymorphism snp technology
    Mean of SUA among the 3 genotypes of SNPs ( SLC2A9 rs1014290, SLC22A12 rs559946 and SLC22A11 rs1783811). (A) The SUA were not significantly different across genotypes of rs1014290, rs559946, and rs1783811 in the total population ( P = .472, P = .498, P = .721); (B) the SUA were not significantly different across genotypes of rs1014290, rs559946, and rs1783811 in the hyperuricemia groups ( P = .922, P = .277, P = .549); (C) the SUA were not significantly different across genotypes of rs1014290, rs559946, and rs1783811 in the control groups ( P = .081, P = .591, P = .805). SLC2A9 = solute carrier family 2 member 9, SLC22A11 = solute carrier family 22 member 11, SLC22A12 = solute carrier family 22 member 12, <t>SNP</t> = single <t>nucleotide</t> polymorphism, SUA = serum uric acid. P < .05 indicates statistical significance.
    Massarray Single Nucleotide Polymorphism Snp Technology, supplied by Sequenom, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/massarray single nucleotide polymorphism snp technology/product/Sequenom
    Average 86 stars, based on 1 article reviews
    massarray single nucleotide polymorphism snp technology - by Bioz Stars, 2026-06
    86/100 stars

    Images

    1) Product Images from "Association of single-nucleotide polymorphisms in SLC2A9, SLC22A12 and SLC22A11 genes with hyperuricemia in the Chinese Tibetan population"

    Article Title: Association of single-nucleotide polymorphisms in SLC2A9, SLC22A12 and SLC22A11 genes with hyperuricemia in the Chinese Tibetan population

    Journal: Medicine

    doi: 10.1097/MD.0000000000045023

    Mean of SUA among the 3 genotypes of SNPs ( SLC2A9 rs1014290, SLC22A12 rs559946 and SLC22A11 rs1783811). (A) The SUA were not significantly different across genotypes of rs1014290, rs559946, and rs1783811 in the total population ( P = .472, P = .498, P = .721); (B) the SUA were not significantly different across genotypes of rs1014290, rs559946, and rs1783811 in the hyperuricemia groups ( P = .922, P = .277, P = .549); (C) the SUA were not significantly different across genotypes of rs1014290, rs559946, and rs1783811 in the control groups ( P = .081, P = .591, P = .805). SLC2A9 = solute carrier family 2 member 9, SLC22A11 = solute carrier family 22 member 11, SLC22A12 = solute carrier family 22 member 12, SNP = single nucleotide polymorphism, SUA = serum uric acid. P < .05 indicates statistical significance.
    Figure Legend Snippet: Mean of SUA among the 3 genotypes of SNPs ( SLC2A9 rs1014290, SLC22A12 rs559946 and SLC22A11 rs1783811). (A) The SUA were not significantly different across genotypes of rs1014290, rs559946, and rs1783811 in the total population ( P = .472, P = .498, P = .721); (B) the SUA were not significantly different across genotypes of rs1014290, rs559946, and rs1783811 in the hyperuricemia groups ( P = .922, P = .277, P = .549); (C) the SUA were not significantly different across genotypes of rs1014290, rs559946, and rs1783811 in the control groups ( P = .081, P = .591, P = .805). SLC2A9 = solute carrier family 2 member 9, SLC22A11 = solute carrier family 22 member 11, SLC22A12 = solute carrier family 22 member 12, SNP = single nucleotide polymorphism, SUA = serum uric acid. P < .05 indicates statistical significance.

    Techniques Used: Control



    Similar Products

    massarray single nucleotide polymorphism snp technology  (Sequenom)
    86
    Sequenom massarray single nucleotide polymorphism snp technology
    Mean of SUA among the 3 genotypes of SNPs ( SLC2A9 rs1014290, SLC22A12 rs559946 and SLC22A11 rs1783811). (A) The SUA were not significantly different across genotypes of rs1014290, rs559946, and rs1783811 in the total population ( P = .472, P = .498, P = .721); (B) the SUA were not significantly different across genotypes of rs1014290, rs559946, and rs1783811 in the hyperuricemia groups ( P = .922, P = .277, P = .549); (C) the SUA were not significantly different across genotypes of rs1014290, rs559946, and rs1783811 in the control groups ( P = .081, P = .591, P = .805). SLC2A9 = solute carrier family 2 member 9, SLC22A11 = solute carrier family 22 member 11, SLC22A12 = solute carrier family 22 member 12, <t>SNP</t> = single <t>nucleotide</t> polymorphism, SUA = serum uric acid. P < .05 indicates statistical significance.
    Massarray Single Nucleotide Polymorphism Snp Technology, supplied by Sequenom, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/massarray single nucleotide polymorphism snp technology/product/Sequenom
    Average 86 stars, based on 1 article reviews
    massarray single nucleotide polymorphism snp technology - by Bioz Stars, 2026-06
    86/100 stars
    		  Buy from Supplier

    Image Search Results


    Mean of SUA among the 3 genotypes of SNPs ( SLC2A9 rs1014290, SLC22A12 rs559946 and SLC22A11 rs1783811). (A) The SUA were not significantly different across genotypes of rs1014290, rs559946, and rs1783811 in the total population ( P = .472, P = .498, P = .721); (B) the SUA were not significantly different across genotypes of rs1014290, rs559946, and rs1783811 in the hyperuricemia groups ( P = .922, P = .277, P = .549); (C) the SUA were not significantly different across genotypes of rs1014290, rs559946, and rs1783811 in the control groups ( P = .081, P = .591, P = .805). SLC2A9 = solute carrier family 2 member 9, SLC22A11 = solute carrier family 22 member 11, SLC22A12 = solute carrier family 22 member 12, SNP = single nucleotide polymorphism, SUA = serum uric acid. P < .05 indicates statistical significance.

    Journal: Medicine

    Article Title: Association of single-nucleotide polymorphisms in SLC2A9, SLC22A12 and SLC22A11 genes with hyperuricemia in the Chinese Tibetan population

    doi: 10.1097/MD.0000000000045023

    Figure Lengend Snippet: Mean of SUA among the 3 genotypes of SNPs ( SLC2A9 rs1014290, SLC22A12 rs559946 and SLC22A11 rs1783811). (A) The SUA were not significantly different across genotypes of rs1014290, rs559946, and rs1783811 in the total population ( P = .472, P = .498, P = .721); (B) the SUA were not significantly different across genotypes of rs1014290, rs559946, and rs1783811 in the hyperuricemia groups ( P = .922, P = .277, P = .549); (C) the SUA were not significantly different across genotypes of rs1014290, rs559946, and rs1783811 in the control groups ( P = .081, P = .591, P = .805). SLC2A9 = solute carrier family 2 member 9, SLC22A11 = solute carrier family 22 member 11, SLC22A12 = solute carrier family 22 member 12, SNP = single nucleotide polymorphism, SUA = serum uric acid. P < .05 indicates statistical significance.

    Article Snippet: DNA was extracted from whole blood samples using Sequenom MassARRAY® single nucleotide polymorphism (SNP) technology.

    Techniques: Control